CA45422-3 - 0x00000000000067A5

Healthy Males & Females

Alchemy

* Stipend may pay up to reflected amount.
Start Date: 
November 4, 2025 - 7:30am
End Date: 
February 24, 2026 - 8:30am

Study Details

Study Number: CA45422
Group Number: 3
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs

Study Information

Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 22

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 6 Returns & 1 Phone Call

Screening Dates (appointments available in Lincoln and Omaha):

Event Day Event Date
Thursday 10/23/2025
Friday 10/31/2025
Monday 11/3/2025

Doctor Exam Dates (appointments available in Lincoln and Omaha):

Event Day Event Date
Thursday 10/23/2025
Friday 10/31/2025
Monday 11/3/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Tuesday 11/4/2025 7:30:00 AM Tuesday 11/4/2025 8:30:00 AM 1L Lincoln
Check-In Monday 11/10/2025 2:00:00 PM Friday 11/14/2025 8:30:00 AM 1 Lincoln
Phone participant Tuesday 11/18/2025 11:30:00 AM 1 Lincoln
Return Tuesday 11/25/2025 7:30:00 AM Tuesday 11/25/2025 8:30:00 AM 1 Lincoln
Return Tuesday 12/9/2025 7:30:00 AM Tuesday 12/9/2025 8:30:00 AM 1 Lincoln
Return Tuesday 1/6/2026 7:30:00 AM Tuesday 1/6/2026 8:30:00 AM 1 Lincoln
Return Tuesday 1/27/2026 7:30:00 AM Tuesday 1/27/2026 8:30:00 AM 1 Lincoln
Return Tuesday 2/24/2026 7:30:00 AM Tuesday 2/24/2026 8:30:00 AM 1 Lincoln